
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Jennifer Edelmann, Karlheinz Holzmann, Eugen Tausch, et al.
Haematologica (2019) Vol. 105, Iss. 5, pp. 1379-1390
Open Access | Times Cited: 36
Jennifer Edelmann, Karlheinz Holzmann, Eugen Tausch, et al.
Haematologica (2019) Vol. 105, Iss. 5, pp. 1379-1390
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 78
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 78
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Erin M. Parry, Ignaty Leshchiner, Romain Guièze, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 158-169
Open Access | Times Cited: 51
Erin M. Parry, Ignaty Leshchiner, Romain Guièze, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 158-169
Open Access | Times Cited: 51
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia
Jenny Klintman, Niamh Appleby, Basile Stamatopoulos, et al.
Blood (2020) Vol. 137, Iss. 20, pp. 2800-2816
Open Access | Times Cited: 73
Jenny Klintman, Niamh Appleby, Basile Stamatopoulos, et al.
Blood (2020) Vol. 137, Iss. 20, pp. 2800-2816
Open Access | Times Cited: 73
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation
Supriya Chakraborty, Claudio Martines, Fabiola Porro, et al.
Blood (2021) Vol. 138, Iss. 12, pp. 1053-1066
Open Access | Times Cited: 54
Supriya Chakraborty, Claudio Martines, Fabiola Porro, et al.
Blood (2021) Vol. 138, Iss. 12, pp. 1053-1066
Open Access | Times Cited: 54
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
Zachary A. Hing, Janek S. Walker, Ethan C. Whipp, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Zachary A. Hing, Janek S. Walker, Ethan C. Whipp, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Functional analysis of structural variants in single cells using Strand-seq
Hyobin Jeong, Karen Grimes, Kerstin K. Rauwolf, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 6, pp. 832-844
Open Access | Times Cited: 26
Hyobin Jeong, Karen Grimes, Kerstin K. Rauwolf, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 6, pp. 832-844
Open Access | Times Cited: 26
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples
Jasneet Kaur Khalsa, Justin Cha, Filippo Utro, et al.
Blood (2023) Vol. 142, Iss. 5, pp. 421-433
Open Access | Times Cited: 14
Jasneet Kaur Khalsa, Justin Cha, Filippo Utro, et al.
Blood (2023) Vol. 142, Iss. 5, pp. 421-433
Open Access | Times Cited: 14
The molecular map of CLL and Richter's syndrome
Amit Sud, Erin M. Parry, Catherine J. Wu
Seminars in Hematology (2024) Vol. 61, Iss. 2, pp. 73-82
Open Access | Times Cited: 5
Amit Sud, Erin M. Parry, Catherine J. Wu
Seminars in Hematology (2024) Vol. 61, Iss. 2, pp. 73-82
Open Access | Times Cited: 5
Lessons learned from the Eµ-TCL1 mouse model of CLL
Alessia Floerchinger, Martina Seiffert
Seminars in Hematology (2024) Vol. 61, Iss. 3, pp. 194-200
Open Access | Times Cited: 3
Alessia Floerchinger, Martina Seiffert
Seminars in Hematology (2024) Vol. 61, Iss. 3, pp. 194-200
Open Access | Times Cited: 3
Telomere Dysfunction in Chronic Lymphocytic Leukemia
Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 19
Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 19
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo
I.A. Lea, N. Ratti, Stéphanie Durand, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1164-1176
Open Access | Times Cited: 2
I.A. Lea, N. Ratti, Stéphanie Durand, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1164-1176
Open Access | Times Cited: 2
Understanding splenic B‐cell lymphoma/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions
Kikkeri N. Naresh
British Journal of Haematology (2024)
Closed Access | Times Cited: 2
Kikkeri N. Naresh
British Journal of Haematology (2024)
Closed Access | Times Cited: 2
Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond
Federico Pozzo, Tamara Bittolo, Erika Tissino, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2997-2997
Open Access | Times Cited: 8
Federico Pozzo, Tamara Bittolo, Erika Tissino, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2997-2997
Open Access | Times Cited: 8
Cell-type specificity of the human mutation landscape with respect to DNA replication dynamics
Madison Caballero, Dominik Boos, Amnon Koren
Cell Genomics (2023) Vol. 3, Iss. 6, pp. 100315-100315
Open Access | Times Cited: 4
Madison Caballero, Dominik Boos, Amnon Koren
Cell Genomics (2023) Vol. 3, Iss. 6, pp. 100315-100315
Open Access | Times Cited: 4
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
Yuwei Li, Yuzheng Xu, Cai-Jin Lin, et al.
Cancer Biology and Medicine (2024), pp. 1-16
Open Access | Times Cited: 1
Yuwei Li, Yuzheng Xu, Cai-Jin Lin, et al.
Cancer Biology and Medicine (2024), pp. 1-16
Open Access | Times Cited: 1
The NOTCH1 and miR-34a signaling network is affected by TP53 alterations in CLL
Alena Sophie Ehrmann, Alex Zadro, Eugen Tausch, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 13, pp. 1941-1953
Open Access | Times Cited: 1
Alena Sophie Ehrmann, Alex Zadro, Eugen Tausch, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 13, pp. 1941-1953
Open Access | Times Cited: 1
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
Daniel Hägerstrand, Blaž Oder, Diego Cortese, et al.
Leukemia (2024)
Open Access | Times Cited: 1
Daniel Hägerstrand, Blaž Oder, Diego Cortese, et al.
Leukemia (2024)
Open Access | Times Cited: 1
The landscape of somatic mutations in lymphoblastoid cell lines
Madison Caballero, Amnon Koren
Cell Genomics (2023) Vol. 3, Iss. 6, pp. 100305-100305
Open Access | Times Cited: 3
Madison Caballero, Amnon Koren
Cell Genomics (2023) Vol. 3, Iss. 6, pp. 100305-100305
Open Access | Times Cited: 3
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
Samantha Teierle, Ying Huang, Adam S. Kittai, et al.
Blood Advances (2023) Vol. 7, Iss. 23, pp. 7239-7242
Open Access | Times Cited: 3
Samantha Teierle, Ying Huang, Adam S. Kittai, et al.
Blood Advances (2023) Vol. 7, Iss. 23, pp. 7239-7242
Open Access | Times Cited: 3
Proteomics and Drug Repurposing in CLL towards Precision Medicine
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Cancers (2021) Vol. 13, Iss. 14, pp. 3391-3391
Open Access | Times Cited: 8
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Cancers (2021) Vol. 13, Iss. 14, pp. 3391-3391
Open Access | Times Cited: 8
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients
Selcen Öztürk, Yashna Paul, Saira Afzal, et al.
Leukemia (2021) Vol. 36, Iss. 2, pp. 464-475
Open Access | Times Cited: 7
Selcen Öztürk, Yashna Paul, Saira Afzal, et al.
Leukemia (2021) Vol. 36, Iss. 2, pp. 464-475
Open Access | Times Cited: 7
Genetic Alteration and Their Significance on Clinical Events in Small Cell Lung Cancer
Shuyue Jiao, Xin Zhang, Dapeng Wang, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 1493-1505
Open Access | Times Cited: 4
Shuyue Jiao, Xin Zhang, Dapeng Wang, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 1493-1505
Open Access | Times Cited: 4
NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia
Jennifer Edelmann
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Jennifer Edelmann
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Outcomes in CLL patients with NOTCH1 regulatory pathway mutations
Daniel Helbig, Ghaith Abu‐Zeinah, Erica B. Bhavsar, et al.
American Journal of Hematology (2021) Vol. 96, Iss. 6
Open Access | Times Cited: 5
Daniel Helbig, Ghaith Abu‐Zeinah, Erica B. Bhavsar, et al.
American Journal of Hematology (2021) Vol. 96, Iss. 6
Open Access | Times Cited: 5
Haplotype-aware single-cell multiomics uncovers functional effects of somatic structural variation
Hyobin Jeong, Karen Grimes, Peter‐Martin Bruch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Hyobin Jeong, Karen Grimes, Peter‐Martin Bruch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4